Publications
42
Citations
867
Est. group size
—
Recurring co-author estimate
Active years
12
Publishing since 2014
Fernando M. Núñez's research focuses on gene therapy approaches for brain tumors, particularly high-grade gliomas including diffuse hemispheric glioma and brainstem glioma. Recent work centers on combining immune-stimulatory gene therapies (using thymidine kinase and Flt3L) with insights into tumor-specific epigenetic mutations (such as H3.3-G34R) to improve treatment effectiveness in mouse models. This research sits at the intersection of cancer biology, immunology, and gene therapy, aiming to develop better treatments for difficult-to-treat brain cancers.
Publication output was low and inconsistent from 2017-2022, followed by a sharp spike in 2023 (largely driven by a single multi-part study with many supplementary components), suggesting activity may be uneven rather than steadily growing.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric Gliomas
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Table S1 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- Supplementary Materials and Methods from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- Figure S8 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- Figure S5 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- Figure S2 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- Figure S6 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- Figure S4 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- Figure S1 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- Figure S7 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- Figure S3 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- Data from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- Data from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- Table S1 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- Supplementary Materials and Methods from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
2023
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Neuro-Oncology×3
- Journal of Clinical Investigation×2
- ACS Nano×1
- Expert Opinion on Therapeutic Targets×1
- Kamalakannan Palanichamy
Medicine · The Ohio State University
- Bradley Elder
Medicine · The Ohio State University
- John R. Jacob
Medicine · The Ohio State University
- Krystof Bankiewicz
Medicine · The Ohio State University
- Susan D. Bell
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile